Twist Bioscience (TWST) Other Working Capital Changes (2017 - 2026)

Twist Bioscience has disclosed Other Working Capital Changes across 10 years of filings, most recently posting $11.1 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes rose 1081.99% year-over-year to $11.1 million; the TTM figure through Mar 2026 stood at $23.5 million (up 1491.58% YoY), while the FY2025 annual figure was $3.7 million, up 1073.04% from the prior year.
• Other Working Capital Changes improved to $11.1 million in Q1 2026, from $7.7 million in the prior quarter.
• Over the last five years, Other Working Capital Changes for TWST reached as high as $11.1 million in Q1 2026 and fell as low as -$1.1 million in Q1 2025.
• The 5-year median for Other Working Capital Changes is $1.1 million (2023), against an average of $1.7 million.
• Annual changes were most pronounced in 2024 — Other Working Capital Changes slumped 268.12% — and 2025, when it jumped 3006.43%.
• A 5-year view of Other Working Capital Changes shows it stood at $1.2 million in 2022, then slipped by 5.18% to $1.1 million in 2023, then sank by 77.69% to $249000.0 in 2024, then jumped by 3006.43% to $7.7 million in 2025, then soared by 43.84% to $11.1 million in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered $11.1 million, $7.7 million, and $1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.